The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Effect of Once- or Twice-Daily MMX Mesalamine (SPD476) for the Induction of Remission of Mild to Moderately Active Ulcerative Colitis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
Sutherland, L. R., Martin, F., Greer, S., Robinson, M., Greenberger, N., Saibil, F., Martin, T., Sparr, J., Prokipchuk, E., & Borgen, L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90621-4 · Cited by 677
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
Kane, S., Huo, D., Aikens, J., & Hanauer, S. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01383-9 · Cited by 569
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 494
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Wang, Y., Parker, C. E., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000544.pub4 · Cited by 483
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
Kane, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)03245-2 · Cited by 429
Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
Kamm, M. A., Sandborn, W. J., Gassull, M., Schreiber, S., Jackowski, L., Butler, T., Lyne, A., Stephenson, D., Palmen, M., & Joseph, R. E. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.011 · Cited by 352
Self-citationvan Staa, T. P., Card, T., Logan, R. F., & Leufkens, H. G. M. (2005) · Gut · doi:10.1136/gut.2005.070896 · Cited by 287
Shale, M. J., & Riley, S. A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01648.x · Cited by 256
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Sutherland, L. R., Roth, D. E., Beck, P. L., May, G. R., & Makiyama, K. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000544 · Cited by 164
Clinicians and patients with hypertension: Unsettled issues about compliance
Rudd, P. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90368-2 · Cited by 163
An Oral Preparation of Mesalamine as Long-Term Maintenance Therapy for Ulcerative Colitis
Hanauer, S. B., Sninsky, C. A., Robinson, M., Powers, B. J., McHattie, J. D., Mayle, J. E., Elson, C. O., DeMicco, M. P., Butt, J. H., Pruitt, R. E., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-2-199601150-00003 · Cited by 155
Predictors of Quality of Life in Ulcerative Colitis.
Han, S. W., McColl, E., Barton, J. R., James, P., Steen, I. N., & Welfare, M. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200501000-00004 · Cited by 140
Determinants of Life Satisfaction in Inflammatory Bowel Disease
Janke, K.-H., Klump, B., Gregor, M., Meisner, C., & Häuser, W. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160809.38611.f7 · Cited by 139
Kane, S. V., Huo, D., & Magnanti, K. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)70032-9 · Cited by 111
Increasing Patient Adherence To Gastroenterology Treatment and Prevention Regimens
Levy, R. L., & Feld, A. D. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01200.x · Cited by 105
Regular review: Ulcerative colitis
Ghosh, S. (2000) · BMJ · doi:10.1136/bmj.320.7242.1119 · Cited by 86
Marteau, P. R., Nelet, F., LU, M. L., & DEVAUX, C. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.92264000.x · Cited by 81
The initiation of colon cancer in a chronic inflammatory setting
Chen, R., Rabinovitch, P. S., Crispin, D. A., Emond, M. J., Bronner, M. P., & Brentnall, T. A. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi106 · Cited by 69
Farup, P. G., Hinterleitner, T. A., Lukáš, M., Hébuterne, X., Rachmilewitz, D., Campieri, M., Meier, R. F., Keller, R., Rathbone, B. J., & Oddsson, E. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00009 · Cited by 66
Standard Treatment of Ulcerative Colitis
Gionchetti, P., Rizzello, F., Habal, F. M., Morselli, C., Amadini, C., Romagnoli, R., & Campieri, M. (2003) · Digestive Diseases · doi:10.1159/000073247 · Cited by 39
Molecular underpinnings of cancer in ulcerative colitis
Brentnall, T. A. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200301000-00011 · Cited by 26
Haghighi, D., & Lashner, B. A. (2004) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.02.008 · Cited by 10
Cited by
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Kornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
Dignass, A., Lindsay, J. O., Sturm, A., Windsor, A., Colombel, J.-F., Allez, M., D'Haens, G., D'Hoore, A., Mantzaris, G., Novacek, G., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.002 · Cited by 1,548
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
Metadata
- Authors
- Lichtenstein, G. R., Kamm, M. A., Boddu, P., Gubergrits, N., Lyne, A., Butler, T., Lees, K., Joseph, R. E., & Sandborn, W. J.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 5
- Issue
- 1
- Pages
- 95-102
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W2020019737
- Cited by
- 267
- References
- 24
- FWCI
- 16.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.